drugset / Trial / NCT01607853

A Short-contact Plaque Test Study With Daivobet® Gel in Psoriasis Vulgaris

NCT01607853

Phase 2 Completed 24 enrolled LEO Pharma
RandomizedSingle-groupSingle-blindOther

Summary

The purpose of this study is to evaluate the anti-psoriatic effect of Daivobet® gel applied then removed after 10 minutes (+/- 2 minutes), Daivobet® gel applied then removed after 20 minutes (+/- 2 minutes) compared with Daivobet® gel and Daivobet® gel vehicle applied for 24 hours (+/- 2 hours), using the psoriasis plaque test modified from the method developed by KJ Dumas and JR Scholtz.

Timeline

Start
2012-06
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Daivobet Unknown

Indications